The latest news from The Hyve on Open Source solutions for bioinformatics

Recent Posts

Kees van Bochove

Kees van Bochove

Kees studied Computer Science and Bioinformatics, for which he did his research project on lipoprotein metabolism at TNO Quality of Life in The Netherlands and the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston. Through his many years of experience in open source software and standards development in bioinformatics, Kees has gained a deep understanding of all aspects of collaborative open source development. He founded The Hyve to facilitate open source software development in bioinformatics and clinical research.

Recent Posts

The Hyve joins project to share genomics data between Canada, Africa and Europe

January 24, 2019 | By Kees van Bochove 0
The CINECA project is a cloud-based data collaboration that will make human omics data from more than a million individuals from Africa, Canada and Europe. It will help to accelerate disease research, drug development and discoveries by providing[…]
[ Read more ]

Webinar: Origins and perspectives for FAIR Data with DTL

November 08, 2018 | By Kees van Bochove 0
Join the webinar on the 16th of November 2018 at 16:00 CET (03:00 PM GMT; 10:00 AM EST).   Update: the video of this webinar is now online:   Digital Transformation is a key goal of many large and small companies, as well as of most research[…]
[ Read more ]

The Hyve in Sprout Challenger50

October 31, 2018 | By Kees van Bochove 0
The Hyve has made the “Sprout Challenger50” for 2018, which lists the top 50 of Dutch scaleups that invent new markets or turn existing business models on its head. We are honoured to be on this exciting list of innovative businesses.
[ Read more ]

Webinar Pistoia Alliance - Wednesday 22nd July

July 22, 2015 | By Kees van Bochove 0
 
[ Read more ]

Preparing for the tranSMART workshop

June 15, 2013 | By Kees van Bochove 0
The next global tranSMART developer and user workshop is coming up next week in Amsterdam, and we are busy preparing for it! Almost 80 people will attend, from pharmaceutical companies, hospitals and universities around the world. We will of course[…]
[ Read more ]
1